Trends in endovascular therapy and clinical outcomes within the nationwide Get With The Guidelines-Stroke registry.
Bijoy K Menon, Jeffrey L Saver, Mayank Goyal...
https://pubmed.ncbi.nlm.nih.gov/25681065/Actively Recruiting
Led by University of Chicago · Updated on 2026-05-20
900
Participants Needed
8
Research Sites
26 weeks
Total Duration
Researchers are evaluating new ways to improve the care of stroke patients who need to be transferred from a local hospital to a specialized stroke center for advanced treatment. This study aims to reduce delays during the initial hospital stay, known as door-in-door-out DIDO time, which can affect timely access to advanced therapies. The study focuses on acute ischemic and hemorrhagic strokes and will test a novel protocol across multiple hospitals in the US to see if it improves patient outcomes and care processes. The study will implement the HI-SPEED Protocol, a set of seven coordinated components including stroke screening scales, imaging pathways, telestroke operations, alerts, communication tools, treatment pathways, and hand-off tools. These will be introduced in clusters of two health systems and compared to the period before implementation. This protocol is designed to streamline evaluation, decision-making, and transfer of stroke patients to comprehensive stroke centers. Participants in this study are hospitals and their stroke patients diagnosed with acute ischemic stroke AIS, intracerebral hemorrhage ICH, or subarachnoid hemorrhage SAH. The study will measure DIDO time as the primary outcome and will also assess disability levels using the Modified Rankin Scale three months after stroke for patients undergoing endovascular therapy. Data will be collected from before and after implementing the protocol, with ongoing monitoring to evaluate effectiveness and quality of care improvements.
CONDITIONS
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
S
Shyam Prabhakaran, MD, MS
J
Jane L Holl, MD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Chicago
Lead Sponsor
University of Miami
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | HI-SPEED Protocol Implementation | Usual Hospital Stroke Care |
|---|---|---|
| What it is | A coordinated protocol for emergency stroke care using seven evidence-based components, such as standardized screening, structured imaging pathways, telestroke support, best practice alerts, team communication tools, thrombolysis workflow, and a standardized hand-off process. | Conventional emergency stroke care as practiced prior to HI-SPEED protocol implementation, utilizing each hospital's established diagnostic and treatment workflow and team communication. |
| Role in trial | Tested as the intervention arm; hospitals implement the full HI-SPEED protocol to improve emergency stroke management. | Serves as the comparator arm; hospitals continue with their prior usual care for emergency stroke patients. |
| Primary use | To improve acute stroke evaluation and treatment times including metrics such as door-in-door-out (DIDO) for ischemic stroke and to enhance coordination of stroke care processes. | Provides a baseline for standard acute stroke management and facilitates assessment of new protocol effectiveness compared to existing practice. |
| How it is given or performed | Implemented across hospital departments; staff apply structured screening, imaging, telestroke consultation, communication protocols, and time-sensitive workflows for thrombolysis as a bundle. | Emergency and neurology teams follow their usual departmental routines for assessment and acute treatment of stroke. May vary by hospital. |
| Evidence status | Ongoing evaluation in a randomized multi-site trial; no published results yet. Prior evidence suggests that structured protocols and reducing time to thrombolysis are associated with improved outcomes in acute ischemic stroke. | Current stroke care processes achieve variable treatment times and patient outcomes. National registry studies show that faster acute intervention, such as rapid door-to-needle times, are correlated with improved survival and functional recovery. |
| Important limitations | Effectiveness is dependent on successful hospital-wide adoption. Implementation quality and adherence to each component can vary by setting and staff training. Actual improvement in outcomes such as treatment speed and functional status is not yet established. | Existing practices may have inconsistent processes for screening, imaging, team activation, and communication, leading to delay and disparities in acute stroke treatment. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of hospital stay during acute stroke care
Participants undergo the HI-SPEED Protocol involving stroke screening scales, imaging pathways, telestroke operations, and other components aimed at improving emergency stroke evaluation and disposition.
Visits occur during hospital stay as part of stroke care
Duration - Up to 3 months post-stroke
Participants are monitored for disability outcomes and recovery following stroke treatment.
1 follow-up visit at 3 months post-stroke
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Bijoy K Menon, Jeffrey L Saver, Mayank Goyal...
https://pubmed.ncbi.nlm.nih.gov/25681065/Jeffrey L Saver, Gregg C Fonarow, Eric E Smith...
https://pubmed.ncbi.nlm.nih.gov/23780461/Scott J Mendelson, Neelum T Aggarwal, Christopher Richards...
https://pubmed.ncbi.nlm.nih.gov/29298854/Craig S Anderson, John Chalmers, Christian Stapf
https://pubmed.ncbi.nlm.nih.gov/24066751/Geoffrey M Curran, Mark Bauer, Brian Mittman...
https://pubmed.ncbi.nlm.nih.gov/22310560/University of Chicago
Lead Sponsor
University of Miami
Collaborating Sponsor